1. Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children

   • Sven Björkman

   Current Opinion 30 September 2012 Pages: 1 - 11

   

2. Significance of the Minor Cytochrome P450 3A Isoforms

   • Ann K. Daly

   Review Article 30 September 2012 Pages: 13 - 31

   

3. Mass Balance Studies, with a Focus on Anticancer Drugs

   • Jan H. Beumer
   • Jos H. Beijnen
   • Jan H. M. Schellens

   Review Article 30 September 2012 Pages: 33 - 58

   

4. Population Pharmacokinetics of Tacrolimus in Whole Blood and Plasma in Asian Liver Transplant Patients

   • Wai Johnn Sam
   • Lai San Tham
   • Paul C. Ho

   Original Research Article 30 September 2012 Pages: 59 - 75

   

5. Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Ximelagatran in Young Healthy Japanese Men

   • Linda C. Wernevik
   • Per Nyström
   • Ulf G. Eriksson

   Original Research Article 30 September 2012 Pages: 77 - 84

   

6. Comparable Pharmacokinetics and Pharmacodynamics of Melagatran in Japanese and Caucasian Volunteers after Oral Administration of the Direct Thrombin Inhibitor Ximelagatran

   • Linda C. Wernevik
   • Per Nyström
   • Ulf G. Eriksson

   Original Research Article 30 September 2012 Pages: 85 - 94

   

7. Compliance-Guided Therapy

   • Alexia Blesius
   • Sylvie Chabaud
   • Patrice Nony

   Original Research Article 30 September 2012 Pages: 95 - 104

   

8. ‘Hedged’ Prescribing for Partially Compliant Patients

   • John Urquhart
   • Bernard Vrijens

   Commentary 30 September 2012 Pages: 105 - 108